Filter
868
Text search:
Antigen
testing
Featured
Recommendations
127
New Publications
227
Language
Document type
No document type
447
Guidelines
198
Studies & Reports
91
Manuals
46
Fact sheets
34
Strategic & Response Plan
30
Training Material
9
Resource Platforms
4
Situation Updates
3
Online Courses
3
Infographics
2
Videos
1
Countries / Regions
India
55
Global
30
South Africa
23
Nigeria
20
Kenya
19
Africa
19
Western and Central Europe
17
Tanzania
16
Zambia
14
East and Southern Africa
14
Sierra Leone
13
Philippines
13
Uganda
12
Germany
12
West and Central Africa
12
Nepal
11
Rwanda
11
Ukraine
11
Liberia
10
Malawi
10
Russia
10
Ghana
9
Latin America and the Carribbean
9
Ethiopia
8
Zimbabwe
8
Namibia
8
Middle East and North Africa
7
Myanmar / Burma
6
Eastern Europe and Central Asia
6
Congo, Democratic Republic of
5
Syria
5
Bangladesh
5
USA
4
Cambodia
4
Mozambique
4
Brazil
4
Eastern Europe
4
Saudi Arabia
3
Cameroon
3
Indonesia
3
Lesotho
3
South–East Asia Region
3
Albania
3
Burkina Faso
2
Somalia
2
Pakistan
2
Iraq
2
Jordan
2
Lebanon
2
Sudan
2
Eswatini/ Swaziland
2
Colombia
2
Libya
2
Asia
2
Iran
2
Guinea
1
Mali
1
Morocco
1
Haiti
1
South Sudan
1
Afghanistan
1
Egypt
1
China
1
Central African Republic
1
Peru
1
North Macedonia
1
Ecuador
1
Botswana
1
Greece
1
Angola
1
Madagascar
1
Chile
1
Yemen
1
Palestine
1
Djibouti
1
Qatar
1
Moldova
1
Kazakhstan
1
Georgia
1
North America
1
Tunisia
1
United Kingdom
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
323
Clinical Guidelines
130
Pharmacy & Technologies
42
Public Health
26
Women & Child Health
18
Key Resources
17
Capacity Building
7
Toolboxes
COVID-19
170
HIV
123
TB
58
Rapid Response
55
NTDs
45
Ebola
36
Refugee
15
Pharmacy
15
Zika
12
AMR
11
Conflict
10
Caregiver
10
Cholera
7
Mental Health
6
Polio
4
Planetary Health
4
Natural Hazards
3
NCDs
3
Global Health Education
2
Health Financing Toolbox
2
The military offensive by the Russian Federation in Ukraine which began February 2022 has triggered one of the world’s fastest-growing displacement and humanitarian crisis, with geopolitical and economic ripples felt across the globe. The ongoing war has caused large-scale disruptions to the deliv
...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i
...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t
...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products
...
This report highlights the work of the World Health Organization (WHO) in Zimbabwe towards contributing to the triple billion targets in the context of the Sustainable Development Goals (SDGs
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o
...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm
...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, including advanced age, smoking, and diabetes, are
...
As the Americas undergo profound demographic change and there are more persons aged 65 years or older than children younger than 5 years, it is crucial to recognize that national immunization programs must be redesigned to ensure comprehensive protection for individuals across the lifespan. By adopt
...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th
...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid
...
On August 13, 2024, the Africa CDC declared the mpox outbreak a Public Health Emergency of Continental Security (PHECS). The following day, the WHO declared it a Public Health Emergency of International Concern (PHEIC). A coordinated, continent-wide response is essential, co-led by the African Union
...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality.
...
The World Health Organization provides regional and national strategies and operational plans that aim to support countries in work to achieve measles control and elimination. These are guided by high level frameworks including the Immunization Agenda 2030 and the Measles and Rubella Strategic Frame
...
As of January 20, 2021 the Covid-19 - living NMA initiative collected 150 RCTs and 36 non-randomised studies of vaccines from the ICTRP. 93 of these trials are recruiting patients.
orientations provisoires, 25 juin 2021. Des tests de diagnostic rapides et précis sont un outil essentiel pour prévenir et contrôler la propagation du COVID-19. Ce document décrit les recommandations relatives aux stratégies nationales de dépistage et à l'utilisation de la PCR et des tests an
...
